SecBot SecBot
144 ·Filed Jun 29, 2026

PSNL

Personalis, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001950047-26-006609
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The filing is routine and not actionable. Monitor for any material changes in the 10b5-1 plan or unexpected acceleration of insider sales, which could signal a shift in management's outlook.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$13.40
T+0 close · Jun 29, 2026 · via day close
Latest settled
+22.01%
T+60 · $16.35
Vs SPY
+19.20%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 30 $13.40entry
  2. T+1 · 5mo ago +2.91%α +3.05% · $13.79
  3. T+5 · 4mo ago +7.01%α +6.41% · $14.34
  4. T+20 · 4mo ago −10.60%α −9.57% · $11.98
  5. T+60 · 8w ago +22.01%α +19.20% · $16.35
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Officer Aaron Tachibana filed a Form 144 notice of intent to sell 4,982 shares of Personalis common stock, valued at approximately $64,866, as part of a pre-arranged 10b5-1 trading plan. The sale is small relative to the $1.4B market cap and follows a pattern of routine plan sales, with over 130,000 shares sold in the prior two months under the same plan.

Key Facts

  • Aaron Tachibana, an officer of Personalis, filed Form 144 to sell 4,982 shares.
  • Proposed sale value approximately $64,866 based on June 29, 2026 market price.
  • Sale is part of a 10b5-1 plan; prior plan sales in May-June 2026 totaled ~130,000 shares for ~$1.6M.
  • Market cap is $1.4B, making the proposed sale de minimis.

Financial Impact

Sale of ~$65k in stock; negligible relative to market cap of $1.4B.

dilution

Risk Factors

  • No material risks identified; insider sales are pre-planned and small.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006609
Document: 0001950047-26-006609-index.html0001950047-26-006609
Document: 0001950047-26-006609.txt0001950047-26-006609

Track record

29 reports on PSNL

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +18.82% at T+60 after the Jul 20, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.16 Now $14.80 −2.34% settles Feb 12
  2. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $15.71 Now $14.80 −5.79% settles Feb 11
  3. Nov 12, 20264d ago 425 Neutral 4/10 Entry $15.86 Now $14.80 −6.68% settles Feb 10
  4. Nov 6, 202610d ago 425 Neutral 3/10 Entry $15.95 Now $14.80 −7.21% settles Feb 5
  5. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $15.55 Now $14.80 −4.82% settles Feb 3
  6. Nov 3, 202613d ago 425 Neutral 3/10 Entry $15.79 Now $14.80 −6.27% settles Feb 2
  7. Oct 30, 202617d ago 425 Neutral 4/10 Entry $15.76 Now $14.80 −6.09% settles Jan 29
  8. Oct 21, 202626d ago DEFM14A Neutral 5/10 Entry $15.82 Now $14.80 −6.45% settles Jan 20
  9. Oct 20, 202627d ago 425 Neutral 4/10 Entry $15.90 Now $14.80 −6.92% settles Jan 19
  10. Oct 20, 202627d ago 425 Neutral 5/10 Entry $15.90 Now $14.80 −6.92% settles Jan 19
Showing 10 of 29

US Market Status

Market Closed · Opens in 8h 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 29, 2026